Latest
Featured in COVID-19
COVID antiviral pills work against Omicron—when people can get them
Oral antivirals hold promise for staving off serious illness, but supplies remain limited.
Why the FDA paused monoclonal antibody treatments
Health experts are supporting limited use of two monoclonal antibody treatments after reports that they were ineffective against Omicron.
Can cannabis protect people from COVID? Buzzy studies can’t say.
Preliminary research shows that very high, pure concentrations of CBD could hamper SARS-CoV-2.
What we know about Omicron’s latest variant
Mutations are normal in widespread viruses, but that doesn't mean they're all harmless.
What to do with your old cloth masks
As experts tell us to upgrade our cloth masks, what do we do with all our extras?
Why healthy, vaccinated people should still care about Omicron
Omicron may be less virulent than previous coronavirus variants, but it’s too early to celebrate
Inside the lab using bones to study COVID and hearing loss
Can highly infectious viruses infect the cells that enable hearing and balance? This Johns Hopkins team wants to find out.
What the Supreme Court’s decision on vaccine mandates means for Americans
Most local mandates will still stand.
Some people still can’t smell or taste a year after COVID
While most infected individuals do recover, some are experiencing long-term changes with their senses.
Tonga is fighting multiple disasters after a historic volcanic explosion
Tonga faces possible new COVID risks as it assesses damage from an eruption and tsunami waves.
